CBD and other hemp-derived products being marketed and sold as foods and dietary supplements are widely available for both human and pet use, despite the fact that the vast majority of these products are illegal at the federal level. Although largely anecdotal evidence shows promise for hemp and CBD products to treat various conditions in pets, many questions remain about safety and efficacy of these products. In addition, if companies decide to market these products, there is associated risk regarding any health-related claims. This webinar will explore the FDA regulatory status of hemp-derived products intended for use in pets, the current state of research regarding benefits, side effects, interaction with other substances, and overall toxicity, and how to minimize the risk of enforcement action regarding claims and other labeling issues.

Get Access

  • +$100 for nonmembers

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.


Bill Bookout, President, National Animal Supplement Council
Isaac Cheng, US Compliance, Canopy Growth Corporation
Jeannie M. Perron, Partner, Covington & Burling LLP

Moderated by Nancy E. Halpern, Partner, Fox Rothschild LLP

Virtual Learning FAQ

On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.


On-demand content can be played back on most devices.


CLE credit is not currently available for pre-recorded sessions.

Related Content